Globus Medical Debt to Equity Ratio 2010-2019 | GMED
Current and historical debt to equity ratio values for Globus Medical (GMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Globus Medical debt/equity for the three months ending September 30, 2019 was 0.00.
| Globus Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-09-30 | $0.00B | $1.34B | 0.00 |
| 2019-06-30 | $0.00B | $1.29B | 0.00 |
| 2019-03-31 | $0.00B | $1.24B | 0.00 |
| 2018-12-31 | $0.00B | $1.19B | 0.00 |
| 2018-09-30 | $0.00B | $1.14B | 0.00 |
| 2018-06-30 | $0.00B | $1.10B | 0.00 |
| 2018-03-31 | $0.00B | $1.03B | 0.00 |
| 2017-12-31 | $0.00B | $0.97B | 0.00 |
| 2017-09-30 | $0.00B | $0.94B | 0.00 |
| 2017-06-30 | $0.00B | $0.91B | 0.00 |
| 2017-03-31 | $0.00B | $0.87B | 0.00 |
| 2016-12-31 | $0.00B | $0.83B | 0.00 |
| 2016-09-30 | $0.00B | $0.81B | 0.00 |
| 2016-06-30 | $0.00B | $0.78B | 0.00 |
| 2016-03-31 | $0.00B | $0.75B | 0.00 |
| 2015-12-31 | $0.00B | $0.72B | 0.00 |
| 2015-09-30 | $0.00B | $0.67B | 0.00 |
| 2015-06-30 | $0.00B | $0.64B | 0.00 |
| 2015-03-31 | $0.00B | $0.61B | 0.00 |
| 2014-12-31 | $0.00B | $0.59B | 0.00 |
| 2014-09-30 | $0.00B | $0.55B | 0.00 |
| 2014-06-30 | $0.00B | $0.53B | 0.00 |
| 2014-03-31 | $0.00B | $0.50B | 0.00 |
| 2013-12-31 | $0.00B | $0.47B | 0.00 |
| 2013-09-30 | $0.00B | $0.45B | 0.00 |
| 2013-06-30 | $0.00B | $0.42B | 0.00 |
| 2013-03-31 | $0.00B | $0.41B | 0.00 |
| 2012-12-31 | $0.00B | $0.39B | 0.00 |
| 2012-09-30 | $0.00B | $0.36B | 0.00 |
| 2012-06-30 | $0.00B | $0.32B | 0.00 |
| 2012-03-31 | $0.00B | $0.30B | 0.00 |
| 2011-12-31 | $0.00B | $0.28B | 0.00 |
| 2011-09-30 | $0.00B | 0.00 | |
| 2011-06-30 | $0.00B | 0.00 | |
| 2011-03-31 | $0.00B | 0.00 | |
| 2010-12-31 | $0.00B | $0.23B | 0.00 |
| 2009-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.255B | $0.713B |
| Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $134.412B | 27.84 |
| Intuitive Surgical (ISRG) | United States | $69.025B | 54.24 |
| Edwards Lifesciences (EW) | United States | $49.387B | 44.85 |
| IDEXX Laboratories (IDXX) | United States | $24.747B | 59.85 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.743B | 15.39 |
| Olympus (OCPNY) | Japan | $21.975B | 165.03 |
| DexCom (DXCM) | United States | $21.449B | 192.08 |
| Teleflex (TFX) | United States | $17.611B | 35.75 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.103B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.585B | 39.26 |
| Hologic (HOLX) | United States | $14.413B | 22.03 |
| Varian Medical Systems (VAR) | United States | $13.427B | 31.83 |
| STERIS (STE) | Ireland | $12.935B | 28.57 |
| Masimo (MASI) | United States | $8.919B | 53.26 |
| ABIOMED (ABMD) | United States | $8.034B | 43.72 |
| SARTORIUS AG (SARTF) | Germany | $6.731B | 59.08 |
| Penumbra (PEN) | United States | $5.577B | 181.51 |
| Integra LifeSciences Holdings (IART) | United States | $5.008B | 21.52 |
| Elekta AB (EKTAY) | Sweden | $4.512B | 38.10 |
| Tandem Diabetes Care (TNDM) | United States | $4.002B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $3.825B | 231.85 |
| Nevro (NVRO) | United States | $3.667B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.586B | 25.81 |
| Integer Holdings (ITGR) | United States | $2.842B | 19.46 |
| Cantel Medical (CMD) | United States | $2.592B | 25.37 |
| Nihon Kohden (NHNKY) | Japan | $2.465B | 24.80 |
| Glaukos (GKOS) | United States | $2.111B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.562B | 30.75 |
| Veracyte (VCYT) | United States | $1.438B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.288B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.180B | 134.78 |
| Natus Medical (NTUS) | United States | $1.160B | 27.89 |
| Mesa Laboratories (MLAB) | United States | $1.143B | 42.39 |
| Inogen (INGN) | United States | $1.119B | 35.33 |
| CryoLife (CRY) | United States | $1.106B | 113.42 |
| Luminex (LMNX) | United States | $1.059B | 0.00 |
| OPKO Health (OPK) | United States | $1.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.024B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.900B | 29.88 |
| OrthoPediatrics (KIDS) | United States | $0.780B | 0.00 |
| Intersect ENT (XENT) | United States | $0.778B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.754B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.713B | 0.00 |
| AxoGen (AXGN) | United States | $0.580B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.560B | 25.66 |
| Si-Bone (SIBN) | United States | $0.531B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.447B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.429B | 12.99 |
| Sientra (SIEN) | United States | $0.385B | 0.00 |
| Stereotaxis (STXS) | United States | $0.346B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.342B | 92.60 |
| Semler Scientific (SMLR) | United States | $0.327B | 45.46 |
| SeaSpine Holdings (SPNE) | United States | $0.300B | 0.00 |
| IRadimed (IRMD) | United States | $0.295B | 41.48 |
| Accuray (ARAY) | United States | $0.289B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.285B | 79.60 |
| ViewRay (VRAY) | United States | $0.281B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.272B | 0.00 |
| Fluidigm (FLDM) | United States | $0.262B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.134B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.120B | 31.77 |
| ConforMIS (CFMS) | United States | $0.093B | 0.00 |
| Electromed (ELMD) | United States | $0.083B | 29.64 |
| Second Sight Medical Products (EYES) | United States | $0.082B | 0.00 |
| Neuronetics (STIM) | United States | $0.078B | 0.00 |
| Vermillion (VRML) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.067B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.060B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.057B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.054B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.039B | 0.00 |
| TransEnterix (TRXC) | United States | $0.032B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.029B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.027B | 0.00 |
| Neovasc (NVCN) | Canada | $0.027B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.026B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.022B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.017B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.016B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.015B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.014B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.17 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.011B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.010B | 0.00 |
| Dynatronics (DYNT) | United States | $0.009B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| InspireMD (NSPR) | Israel | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
